Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples